Does Cholamandalam Investment and Finance Company Limited's (NSE:CHOLAFIN) Stock Price Account For Its Growth?

Cholamandalam Investment and Finance Company Limited (NSE:CHOLAFIN) is considered a high growth stock. However its last closing price of ₹1458.4 left investors wondering whether this growth has already been factored into the share price. Let’s take a look at some key metrics to determine whether there's any value here for current and potential future investors.

View our latest analysis for Cholamandalam Investment and Finance

Advertisement

Where's the growth?

Cholamandalam Investment and Finance's growth potential is very attractive. The consensus forecast from 14 analysts is extremely positive with earnings per share estimated to rise from today's level of ₹62.407 to ₹113.24 over the next three years. This indicates an estimated earnings growth rate of 17.4% per year, on average, which signals a market-beating outlook in the upcoming years.

Is CHOLAFIN's share price justifiable by its earnings growth?

CHOLAFIN is trading at price-to-earnings (PE) ratio of 23.39x, which suggests that Cholamandalam Investment and Finance is overvalued based on current earnings compared to the consumer finance industry average of 23.01x , and overvalued compared to the IN market average ratio of 20.32x . This multiple is a median of profitable companies of 25 Consumer Finance companies in IN including Wall Street Finance, SI Capital & Financial Services and Transcorp International.

NSEI:CHOLAFIN PE PEG Gauge August 27th 18
NSEI:CHOLAFIN PE PEG Gauge August 27th 18

After looking at CHOLAFIN's value based on current earnings, we can see it seems overvalued relative to other companies in the industry. But, since Cholamandalam Investment and Finance is a high-growth stock, we must also account for its earnings growth by using calculation called the PEG ratio. A PE ratio of 23.39x and expected year-on-year earnings growth of 17.4% give Cholamandalam Investment and Finance a higher PEG ratio of 1.35x. This means that, when we account for Cholamandalam Investment and Finance's growth, the stock can be viewed as slightly overvalued , based on its fundamentals.

What this means for you:

CHOLAFIN's current overvaluation could signal a potential selling opportunity to reduce your exposure to the stock, or it you're a potential investor, now may not be the right time to buy. However, basing your investment decision off one metric alone is certainly not sufficient. There are many things I have not taken into account in this article and the PEG ratio is very one-dimensional. If you have not done so already, I urge you to complete your research by taking a look at the following:

  1. Financial Health: Are CHOLAFIN’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  2. Past Track Record: Has CHOLAFIN been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of CHOLAFIN's historicals for more clarity.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

About NSEI:CHOLAFIN

Cholamandalam Investment and Finance

Operates as a non-banking finance company in India.

High growth potential with proven track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5360.5% undervalued
135 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18053.1% undervalued
19 users have followed this narrative
1 users have commented on this narrative
12 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.315.7% undervalued
10 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2454.2% undervalued
30 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

MA
MarkoVT
5253 logo
MarkoVT on COVER ·

Significant headwinds will temper expectations for FY2027

Fair Value:JP¥2.28k36.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
UNCY logo
kapirey on Unicycive Therapeutics ·

Unicycive Therapeutics is a late-stage clinical biotech transitioning toward commercialization

Fair Value:US$9.177.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
1364 logo
kapirey on Guming Holdings ·

A scaled, high-growth, franchise-driven beverage leader with strong penetration in China

Fair Value:HK$47.5650.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.8% undervalued
108 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.226.0% undervalued
70 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74016.7% undervalued
36 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative